These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [The significance of the PAS-reaction in myeloproliferative diseases]. Krug K; Stenzel L Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 91(2):307-13. PubMed ID: 4184596 [No Abstract] [Full Text] [Related]
4. [A "myeloproliferative syndrome" of long duration (author's transl)]. Kühböck J; Peskar BM; Vormittag W Med Klin; 1974 Mar; 69(10):423-6. PubMed ID: 4524608 [No Abstract] [Full Text] [Related]
9. Carcinoma of the lung presenting with a myeloproliferative disorder. A report of two patients. McIllmurray MB; Ryrie DR; Fletcher J Postgrad Med J; 1977 Nov; 53(625):702-4. PubMed ID: 201931 [TBL] [Abstract][Full Text] [Related]
10. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases. Orazi A Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881 [TBL] [Abstract][Full Text] [Related]
11. Thrombocythemia in the myeloproliferative disorder of Down's syndrome. Miller JM; Sherrill JG; Hathaway WE Pediatrics; 1967 Nov; 40(5):847-50. PubMed ID: 4229443 [No Abstract] [Full Text] [Related]
12. [Prognostic value of bone marrow biopsy in chronic myeloproliferative disorders]. Bettini R; Marzetta K; Miglioranza A; Redaelli S; Maino C; Maffiolini A; Gorini M Recenti Prog Med; 2003; 94(7-8):314-20. PubMed ID: 12868237 [TBL] [Abstract][Full Text] [Related]
14. [Problems of the myeloproliferative syndrome from the pathologist's viewpoint]. Werner W Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 91(2):227-34. PubMed ID: 4184585 [No Abstract] [Full Text] [Related]
15. [Novel method in diagnosis of chronic myeloproliferative disorders--detection of JAK2 mutation]. Rajnai H; Bödör C; Reiniger L; Timár B; Csernus B; Szepesi A; Csomor J; Matolcsy A Orv Hetil; 2006 Nov; 147(45):2175-9. PubMed ID: 17402211 [TBL] [Abstract][Full Text] [Related]
16. Idiopathic myelofibrosis. Clinical aspects and studies on extracellular matrix metabolism. Hasselbalch HC Dan Med Bull; 1993 Mar; 40(1):39-55. PubMed ID: 8472598 [No Abstract] [Full Text] [Related]
17. Aberrant expression of transforming growth factor beta-1 (TGF beta-1) per se does not discriminate fibrotic from non-fibrotic chronic myeloproliferative disorders. Bock O; Loch G; Schade U; von Wasielewski R; Schlué J; Kreipe H J Pathol; 2005 Apr; 205(5):548-57. PubMed ID: 15726648 [TBL] [Abstract][Full Text] [Related]
18. Myelofibrosis--what's in a name? Consensus on definition and EUMNET grading. Thiele J; Kvasnicka HM Pathobiology; 2007; 74(2):89-96. PubMed ID: 17587880 [TBL] [Abstract][Full Text] [Related]
19. Comments on feline leukemia: clinical and pathologic features, differential diagnosis. Schalm OW J Am Vet Med Assoc; 1971 Mar; 158(6):Suppl 2:1025+. PubMed ID: 5280564 [No Abstract] [Full Text] [Related]
20. [Atypical myeloproliferative disorders: a study on 3 cases showing pancytopenia, marrow fibrosis and the absence of splenomegaly]. Yoshida Y; Yamagishi M; Fukuhara S; Sawada H; Ohkuma M; Uchino H; Nakamura T Rinsho Ketsueki; 1984 Mar; 25(3):383-92. PubMed ID: 6471435 [No Abstract] [Full Text] [Related] [Next] [New Search]